MDCX 424B5: Secondary offering

Filed with the SEC on · accession 0001062993-26-006029

MDCX filed a 424B5 (prospectus (offering)) with the SEC on Nov 16, 2026. Medicus Pharma Ltd. is conducting a registered direct offering of 97,973 common shares and pre-funded warrants to purchase up to 1,646,213 common shares at $1.72 per share, raising approximately $3.0 million in gross proceeds. The stock moved +0.5% by the first close after the filing.

Summary of the filing

Medicus Pharma Ltd. is conducting a registered direct offering of 97,973 common shares and pre-funded warrants to purchase up to 1,646,213 common shares at $1.72 per share, raising approximately $3.0 million in gross proceeds. Concurrently, the company is completing a private placement of 726,730 common shares for approximately $1.25 million and exchanging $10.5 million of debt for 105,000 preferred shares with Streeterville Capital, LLC.

Key details

Gross proceeds from registered direct offering$3.0M
Gross proceeds from concurrent private placement$1.3M
Principal amount of debt exchanged for preferred shares$10.5M
Offering price per common share$2
Offering price per pre-funded warrant$2
IssuerMedicus Pharma Ltd.
Debt holder exchanging debt for preferred sharesStreeterville Capital, LLC
Executive chairman and chief executive officerDr. Raza Bokhari

How MDCX stock reacted

Close before

$1.95

Nov 13, 2026

First close after

+0.51%

$1.96

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MDCX?

Click here

Frequently asked questions

What did MDCX file with the SEC on Nov 16, 2026?

MDCX filed a 424B5 (Secondary offering). Medicus Pharma Ltd. is conducting a registered direct offering of 97,973 common shares and pre-funded warrants to purchase up to 1,646,213 common shares at $1.72 per share, raising approximately $3.0 million in gross proceeds. Concurrently, the company is completing a private placement of 726,730 common shares for approximately $1.25 million and exchanging $10.5 million of debt for 105,000 preferred shares with Streeterville Capital, LLC.

What does a secondary offering mean for MDCX stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B5?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did MDCX stock react to this filing?

MDCX closed at $1.95 before the filing and $1.96 on Nov 16, 2026 (+0.51%).

Other MDCX SEC filings

Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days